Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Caredx Inc (NASDAQ: CDNA) closed at $30.62 in the last session, up 0.29% from day before closing price of $30.53. In other words, the price has increased by $0.29 from its previous closing price. On the day, 0.6 million shares were traded. CDNA stock price reached its highest trading level at $31.005 during the session, while it also had its lowest trading level at $29.51.
Ratios:
We take a closer look at CDNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 4.09. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Underweight rating and assigned the stock a target price of $28.
On August 19, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $40.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 20 ’24 when Johnson Alexander L sold 39,466 shares for $33.17 per share. The transaction valued at 1,309,087 led to the insider holds 284,983 shares of the business.
Johnson Alexander L sold 21,557 shares of CDNA for $702,327 on Aug 21 ’24. The insider now owns 284,983 shares after completing the transaction at $32.58 per share. On Aug 20 ’24, another insider, Maag Peter, who serves as the Director of the company, sold 35,552 shares for $33.04 each. As a result, the insider received 1,174,493 and left with 330,024 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1614898816 and an Enterprise Value of 1417476096. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.44 while its Price-to-Book (P/B) ratio in mrq is 6.09. Its current Enterprise Value per Revenue stands at 4.771 whereas that against EBITDA is -22.733.
Stock Price History:
Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $4.80. The 50-Day Moving Average of the stock is 4.28%, while the 200-Day Moving Average is calculated to be 86.77%.
Shares Statistics:
According to the various share statistics, CDNA traded on average about 943.59K shares per day over the past 3-months and 950940 shares per day over the past 10 days. A total of 51.50M shares are outstanding, with a floating share count of 49.35M. Insiders hold about 6.43% of the company’s shares, while institutions hold 96.87% stake in the company. Shares short for CDNA as of 1727654400 were 3658174 with a Short Ratio of 3.88, compared to 1724976000 on 3307352. Therefore, it implies a Short% of Shares Outstanding of 3658174 and a Short% of Float of 9.2.
